Literature DB >> 8873006

Splenectomy-reduced hepatic injury induced by ischemia/reperfusion in the rat.

Y Okuaki1, H Miyazaki, M Zeniya, T Ishikawa, Y Ohkawa, S Tsuno, M Sakaguchi, M Hara, H Takahashi, G Toda.   

Abstract

In the present study, we investigated the role of the spleen in experimental hepatic ischemia/reperfusion in the rat. After a 90-min period of ischemia in the left and middle hepatic lobes, the ischemia was released and the liver was reperfused for up to 24 h. Plasma alanine aminotransferase reached a peak 3 h after the onset of reperfusion, and gradually decreased thereafter. A histological examination revealed evidence of hepatocellular necrosis and degeneration, especially 24 h after the onset of reperfusion. In addition, there was a noticeable accumulation of polymorphonuclear cells in the liver following ischemia/reperfusion. A splenectomy performed just prior to ischemia/reperfusion reduced both biochemical and histological hepatocellular injury. The number of polymorphonuclear cells in the liver following ischemia/reperfusion was significantly reduced in rats subjected to splenectomy, suggesting that the increase in polymorphonuclear cells may contribute to liver injury. The number of mononuclear cells also increased in the marginal zones of the spleen following ischemia/reperfusion, and appeared to be derived from the splenic monocyte/macrophage population, based on immunohistochemical studies. The spleen plays an important role in the pathogenesis of hepatic ischemia/reperfusion injury and the splenic monocyte/ macrophage population contributes to liver damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8873006     DOI: 10.1111/j.1600-0676.1996.tb00726.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  23 in total

Review 1.  Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury.

Authors:  Rosanna Di Paola; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-13       Impact factor: 3.000

2.  Blockade of adrenoreceptors inhibits the splenic response to stroke.

Authors:  Craig T Ajmo; Lisa A Collier; Christopher C Leonardo; Aaron A Hall; Suzanne M Green; Tracy A Womble; Javier Cuevas; Alison E Willing; Keith R Pennypacker
Journal:  Exp Neurol       Date:  2009-04-14       Impact factor: 5.330

3.  The splenic response to ischemic stroke: what have we learned from rodent models?

Authors:  Christopher C Leonardo; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2011-04-03       Impact factor: 6.829

Review 4.  Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure.

Authors:  Stephen F Rodrigues; D Neil Granger
Journal:  Cardiovasc Res       Date:  2010-03-17       Impact factor: 10.787

5.  Targeting the peripheral inflammatory response to stroke: role of the spleen.

Authors:  Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2014-09-26       Impact factor: 6.829

6.  A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation.

Authors:  Hilary A Seifert; Aaron A Hall; Cortney B Chapman; Lisa A Collier; Alison E Willing; Keith R Pennypacker
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-06       Impact factor: 4.147

7.  Progenitor cells: therapeutic targets after traumatic brain injury.

Authors:  Robert A Hetz; Supinder S Bedi; Scott Olson; Alex Olsen; Charles S Cox
Journal:  Transl Stroke Res       Date:  2012-05-22       Impact factor: 6.829

8.  CCL20 Is Associated with Neurodegeneration Following Experimental Traumatic Brain Injury and Promotes Cellular Toxicity In Vitro.

Authors:  Christopher C Leonardo; James Musso; Mahasweta Das; Derrick D Rowe; Lisa A Collier; Shyam Mohapatra; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2012-08-09       Impact factor: 6.829

9.  Implications of immune system in stroke for novel therapeutic approaches.

Authors:  Aaron A Hall; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2010-01-13       Impact factor: 6.829

10.  Protective effects of early CD4(+) T cell reduction in hepatic ischemia/reperfusion injury.

Authors:  Mathias Martin; Christina Mory; Andrea Prescher; Christian Wittekind; Martin Fiedler; Dirk Uhlmann
Journal:  J Gastrointest Surg       Date:  2009-11-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.